Vertex Pharmaceuticals Inc VRTX:NASDAQ

Last Price$265.69NASDAQ Previous Close - Last Trade as of 4:15PM ET 6/05/20
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$263.76 (1)
Ask (Size)$267.20 (6)
Day Low / HighN/A - N/A
Volume2.8 M

FDA Accepts Vertex Pharmaceuticals' New Drug Application for Cystic Fibrosis Triple Combination Regimen

8:40AM ET 8/20/2019 MT Newswires
Vertex Pharmaceuticals (VRTX) said pre-market Tuesday that the US Food and Drug Administration has accepted its New Drug Application (NDA) for the VX-445 (elexacaftor), tezacaftor and ivacaftor triple combination regimen for the treatment of cystic fibrosis.

The regulatory agency has granted Priority Review of the NDA and assigned a Prescription Drug User Fee Act target action date of March 19, the biotechnology company said.

Price: 187.09, Change: +2.15, Percent Change: +1.16